Increases in serum FGF21 are observed in coronary artery disease, cardiac hypertrophy, and diabetic cardiomyopathy, often paralleling rises in brain natriuretic peptide (BNP) as part of a compensatory response. The gene discussed is NPPB; the disease is diabetic cardiomyopathy.